AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Featuring perspectives from Dr Karim Fizazi, Dr Daniel George and Dr Elisabeth I Heath, moderated by Dr Heath, including the following topics:
- Role of PTEN deficiency in tumorigenesis of prostate cancer and optimal approach to PTEN assessment — Question from Neeraj Agarwal, MD, FASCO (0:00)
- Case: A man in his late 60s with a history of nonmetastatic hormone-sensitive prostate cancer (HSPC) that progressed to metastatic HSPC with PTEN loss by next-generation sequencing of primary archival tissue from 2017 receives abiraterone for 2 years — Rana R McKay, MD, FASCO (8:26)
You May Also Like

BrainStuff
iHeartPodcasts

New Books in Public Policy
New Books Network

New Books in Political Science
New Books Network

MinuteEarth
Minute Earth

Something You Should Know
Mike Carruthers | OmniCast Media

BirdNote Daily
BirdNote

Meteor
Český rozhlas

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Ologies with Alie Ward
Alie Ward
Community discussion